Could This $25 Shot End HIV?

A new HIV-prevention shot, lenacapavir, is about to hit the US, and get this: researchers say it could be made for just $25 a year! But the pharma giant behind it might charge up to $25,000 instead. Activists and experts are calling out the huge markup, saying affordable access could actually end the HIV pandemic. Imagine if a life-saving drug was finally cheap enough for everyone who needs it. Will Gilead step up or stick to sky-high prices? #HIVPrevention #HealthNews #BigPharma #Health #BodyHealth